Hetero-oligomerization and Specificity Changes of G Protein-Coupled Purinergic Receptors

2013 ◽  
pp. 239-257 ◽  
Author(s):  
Tokiko Suzuki ◽  
Kazunori Namba ◽  
Natsumi Mizuno ◽  
Hiroyasu Nakata
Keyword(s):  
G Protein ◽  
Purinergic Receptors ◽  
G Protein Coupled

scholarly journals Purinergic Receptors Crosstalk with CCR5 to Amplify Ca2+ Signaling

2020 ◽  
Author(s):  
Mizuho Horioka ◽  
Emilie Ceraudo ◽  
Emily Lorenzen ◽  
Thomas P. Sakmar ◽  
Thomas Huber
Keyword(s):  
Signaling Pathways ◽  
G Protein ◽  
Purinergic Receptors ◽  
P2y Receptors ◽  
G Protein Signaling ◽  
Protein Signaling ◽  
Extracellular Milieu ◽  
Immunodeficiency Virus ◽  
Intracellular Ca ◽  
G Protein Coupled

AbstractMany G protein-coupled receptors (GPCRs) signal through more than one subtype of heterotrimeric G proteins. For example, the C–C chemokine receptor type 5 (CCR5), which serves as a co-receptor to facilitate cellular entry of human immunodeficiency virus 1 (HIV-1), normally signals through the heterotrimeric G protein, Gi. However, CCR5 also exhibits G protein signaling bias and certain chemokine analogs can cause a switch to Gq pathways to induce Ca2+ signaling. We want to understand how much of the Ca2+ signaling from Gi-coupled receptors is due to G protein promiscuity and how much is due to transactivation and crosstalk with other receptors. We propose a possible mechanism underlying the apparent switching between different G protein signaling pathways. We show that chemokine-mediated Ca2+ flux in HEK293T cells expressing CCR5 can be primed and enhanced by ATP pretreatment. In addition, agonist-dependent lysosomal exocytosis results in the release of ATP to the extracellular milieu, which amplifies cellular signaling networks. ATP is quickly degraded via ADP and AMP to adenosine. ATP, ADP and adenosine activate different cell surface purinergic receptors. Endogenous Gq-coupled purinergic P2Y receptors amplify Ca2+ signaling and allow for Gi- and Gq-coupled receptor signaling pathways to converge. Associated secretory release of GPCR ligands, such as chemokines, opioids, and monoamines, should also lead to concomitant release of ATP with a synergistic effect on Ca2+ signaling. Our results suggest that crosstalk between ATP-activated purinergic receptors and other Gi-coupled GPCRs is an important cooperative mechanism to amplify the intracellular Ca2+ signaling response.

scholarly journals P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases

2020 ◽  
Vol 21 (18) ◽  
pp. 6855 ◽  
Author(s):  
Derek Strassheim ◽  
Alexander Verin ◽  
Robert Batori ◽  
Hala Nijmeh ◽  
Nana Burns ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Cardiovascular Diseases ◽  
Endothelial Dysfunction ◽  
Cardiovascular System ◽  
G Protein ◽  
Purinergic Receptors ◽  
G Protein Coupled Receptors ◽  
Receptor Subtypes ◽  
Activated State ◽  
G Protein Coupled

Purinergic G-protein-coupled receptors are ancient and the most abundant group of G-protein-coupled receptors (GPCRs). The wide distribution of purinergic receptors in the cardiovascular system, together with the expression of multiple receptor subtypes in endothelial cells (ECs) and other vascular cells demonstrates the physiological importance of the purinergic signaling system in the regulation of the cardiovascular system. This review discusses the contribution of purinergic P2Y receptors to endothelial dysfunction (ED) in numerous cardiovascular diseases (CVDs). Endothelial dysfunction can be defined as a shift from a “calm” or non-activated state, characterized by low permeability, anti-thrombotic, and anti-inflammatory properties, to a “activated” state, characterized by vasoconstriction and increased permeability, pro-thrombotic, and pro-inflammatory properties. This state of ED is observed in many diseases, including atherosclerosis, diabetes, hypertension, metabolic syndrome, sepsis, and pulmonary hypertension. Herein, we review the recent advances in P2Y receptor physiology and emphasize some of their unique signaling features in pulmonary endothelial cells.

scholarly journals Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands

2015 ◽  
Vol 98 ◽  
pp. 58-67 ◽  
Author(s):  
Francisco Ciruela ◽  
Víctor Fernández-Dueñas ◽  
Kenneth A. Jacobson
Keyword(s):  
G Protein ◽  
Purinergic Receptors ◽  
Fluorescent Ligands ◽  
G Protein Coupled

A compendium of G-protein–coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure

2020 ◽  
Vol 134 (5) ◽  
pp. 473-512 ◽  
Author(s):  
Ryan P. Ceddia ◽  
Sheila Collins
Keyword(s):  
Adipose Tissue ◽  
Energy Expenditure ◽  
Signaling Pathways ◽  
G Protein ◽  
Uncoupling Protein ◽  
Beige Adipocytes ◽  
Nucleotide Regulation ◽  
Ucp1 Expression ◽  
Thermogenic Adipocytes ◽  
G Protein Coupled

Abstract With the ever-increasing burden of obesity and Type 2 diabetes, it is generally acknowledged that there remains a need for developing new therapeutics. One potential mechanism to combat obesity is to raise energy expenditure via increasing the amount of uncoupled respiration from the mitochondria-rich brown and beige adipocytes. With the recent appreciation of thermogenic adipocytes in humans, much effort is being made to elucidate the signaling pathways that regulate the browning of adipose tissue. In this review, we focus on the ligand–receptor signaling pathways that influence the cyclic nucleotides, cAMP and cGMP, in adipocytes. We chose to focus on G-protein–coupled receptor (GPCR), guanylyl cyclase and phosphodiesterase regulation of adipocytes because they are the targets of a large proportion of all currently available therapeutics. Furthermore, there is a large overlap in their signaling pathways, as signaling events that raise cAMP or cGMP generally increase adipocyte lipolysis and cause changes that are commonly referred to as browning: increasing mitochondrial biogenesis, uncoupling protein 1 (UCP1) expression and respiration.

Sign in / Sign up

Export Citation Format

Share Document